Filtered By:
Drug: Beta-Blockers

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 458 results found since Jan 2013.

Impact of Gender on Type II Diabetes Glycemic and Cardiovascular Markers Control and Treatment
CONCLUSION: Both genders exhibited comparable HbA1c levels. Medical treatment optimization along with controlling both measured cardiovascular makers and laboratory result levels was based on comorbidities and complications rather than gender.PMID:33274898 | DOI:10.3923/pjbs.2020.1643.1649
Source: Pakistan Journal of Biological Sciences: PJBS - December 4, 2020 Category: Biomedical Science Authors: Khaled A Alswat Source Type: research

Effect of non-adherence of evidence-based medication prescribing on major adverse cardiovascular events among acute coronary syndrome patients
Background and Aims: Combination therapy with evidence-based medicines, including 4 groups of medication: dual antiplatelet, beta-blocker, ACEI /ARB, and statin, could reduce the risk of morbidity and mortality among patients with the acute coronary syndrome (ACS). This retrospective cohort study aimed to compare the risk of major adverse cardiovascular events (MACE) including cardiovascular death, myocardial infarction, unstable angina, and stroke during the first year of discharge between ACS patients received 4 groups and those did not receive at least 1 medication group.
Source: Atherosclerosis - December 1, 2020 Category: Cardiology Authors: S. Chinwong, M. Chommontha, S. Kammanat, A. Phrommintikul, D. Chinwong Source Type: research

Statins and beta blockers - The most frequently encountered potential prescribing omissions in rural Romanian elderly population
Background and Aims: Cardiovascular diseases (ischaemic heart diseases and stroke) are the leading cause of death in Romania, the death rate of ischaemic heart disease being three times higher than in European Union. The aim of this study was to identify potential prescribing omissions (PPOs) and to determine their prevalence based on the STOPP / START v.2, 2015, criteria for patients over the age of 65 years old.
Source: Atherosclerosis - December 1, 2020 Category: Cardiology Authors: V.O. Buda, O. Dalleur, A. Prelipcean, S. Buda, M. Andor, D.E. Baibata, A. Dohou, L. Petrescu, C. Cristescu Source Type: research

Beta-blockers in refractory ascites – is it truly the end of the road?
We read with great interest the study by Tellez et  al.1 highlighting mechanisms of hemodynamic alterations and associated renal dysfunction with the use of a 4-week non-selective beta-blocker (NSBB) therapy in refractory ascites (RA) and diuretic responsive ascites (DRA).1 They proposed ejection intra-ventricular pressure difference (EIVPD) as a n ovel load-independent measure that predicts LV systolic function decline better than standard load-dependent measures (ejection fraction and stroke volume).
Source: Journal of Hepatology - August 26, 2020 Category: Gastroenterology Authors: Rohit Mehtani, Akash Roy, Nipun Verma, Madhumita Premkumar, Virendra Singh Tags: Letter to the Editor Source Type: research

Transthyretin cardiac amyloidosis.
Authors: Eicher JC, Audia S, Damy T Abstract Transthyretin (TTR) cardiac amyloidosis results from the dissociation of the tetrameric, liver-synthetized transport protein, either because of a mutation (hereditary CA), or spontaneously due to ageing (wild type CA). Monomers self-associate into amyloid fibrils within the myocardium, causing heart failure, arrhythmias and conduction defects. This overlooked disease must be recognized in case of unexplained increased thickness of the myocardium, particularly in subjects of African descent, in patients with heart failure and preserved ejection fraction, and in those with...
Source: Revue de Medecine Interne - August 23, 2020 Category: Internal Medicine Tags: Rev Med Interne Source Type: research

Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials
Conclusion: Compared with other antihypertensive agents, beta-blockers appear to be substantially less protective against stroke and overall mortality. However, they exhibit a substantial risk-reducing ability for all events when prescribed to lower BP in patients with modest or more clear BP elevations, and therefore can be used as additional agents in hypertensive patients.
Source: Journal of Hypertension - August 13, 2020 Category: Cardiology Tags: REVIEWS AND META-ANALYSES Source Type: research

Recent Advances in the Management of Migraine in Older Patients
AbstractAlthough the prevalence of migraine tends to decrease in the fifth to sixth decades of life, there are still a significant number of patients  >  65 years of age who experience migraine or have new-onset migraine. Because these older patients are often excluded from clinical trials, there are fewer evidence-based treatment guidelines for them. Migraine treatment in the older population requires careful consideration of changes in medicati on metabolism and increased medical comorbidities. Furthermore, older patients can present with an atypical migraine phenotype and have a higher rate of secondary headache...
Source: Drugs and Aging - June 22, 2020 Category: Geriatrics Source Type: research

Determining Safe Participation in Aerobic Exercise Early After Stroke Through a Graded Submaximal Exercise Test.
CONCLUSION: A graded submaximal exercise test without ECG but with symptom monitoring and conservative heart rate and perceived exertion endpoints may facilitate safe exercise intensities early after stroke. Symptom-limited exercise testing with ECG is still recommended when progressing to higher-intensity exercise. IMPACT: Concerns about cardiovascular risk are a barrier to physical therapists implementing aerobic exercise in stroke rehabilitation. This study showed that, in the absence of access to exercise testing with ECG, submaximal testing with conservative heart rate and perceived exertion endpoints and symptom...
Source: Physical Therapy - June 2, 2020 Category: Physiotherapy Authors: Inness E, Aqui A, Foster E, Fraser J, Danells CJ, Biasin L, Brunton K, Howe JA, Poon V, Tang A, Mansfield A, Marzolini S, Oh P, Bayley M Tags: Phys Ther Source Type: research

Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis.
CONCLUSIONS: ACEi/ARB and MRA can be safely used in CA, provided that no contraindications are present, treatment is started at a low dose and slowly up-titrated, and patients are monitored quite closely. Beta-blocker therapy is less tolerated in patients with AL amyloidosis and/or worse haemodynamic function. PMID: 32475765 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - May 27, 2020 Category: Internal Medicine Authors: Aimo A, Vergaro G, Castiglione V, Rapezzi C, Emdin M Tags: Eur J Intern Med Source Type: research

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Evidence-based Review About Mechanism, Complications and Management
Hypertrophic cardiomyopathy (HCM) is 1 of the most frequent genetic cardiovascular diseases affecting 1 out of every 500 individuals in general population. Atrial Fibrillation incidences were 3.8% per 100 patients per year and overall prevalence among HCM patients are 27.09%. Higher risk of death noted in HCM patients with atrial fibrillation. Stroke and other thrombo embolic risks are increased in such patients. Medical management using mainly betablockers or amiodarone produced variable results and high rate of recurrence. Catheter ablation reduced symptom burden and complications despite moderate recurrence. Patients wi...
Source: Critical Pathways in Cardiology - May 16, 2020 Category: Cardiology Tags: Review Article Source Type: research

Is Arterial Stiffness a Determinant of Hypotension?
ConclusionsHypotension is a quite common phenomenon in older subjects. Its prevention requires a more accurate management of hypertension aimed at better identifying which older subjects in whom intensive BP control may be harmful and those who may benefit from it.
Source: High Blood Pressure and Cardiovascular Prevention - May 7, 2020 Category: Cardiology Source Type: research

Diagnosis and management of acute aortic syndromes in the emergency department
AbstractAcute aortic syndromes (AASs) are deadly cardiovascular emergencies involving the thoracic aorta. AASs are relatively rare conditions, have unspecific signs and symptoms (including truncal pain, syncope, neurologic deficit and limb ischemia) and require contrast-enhanced tomography angiography (CTA) of the chest and abdomen for conclusive diagnosis and subsequent therapeutic planning. In the Emergency Department (ED), most patients with potential signs/symptoms of AASs are finally found affected by other alternative diagnoses. Hence, misdiagnosis and delayed diagnosis of AASs are major concerns. In critically ill p...
Source: Internal and Emergency Medicine - April 30, 2020 Category: Emergency Medicine Source Type: research

Contrast-Induced Acute Kidney Injury in Radiologic Management of Acute Ischemic Stroke in the Emergency Setting INTERVENTIONAL
CONCLUSIONS: Patients with low baseline renal function had the highest incidence of postcontrast acute kidney injury after CTA and cerebral angiography, but no fatal adverse effects were documented. Thus, patients suspected of having a stroke should be actively managed with respect to neurovascular function.
Source: American Journal of Neuroradiology - April 8, 2020 Category: Radiology Authors: Myung, J. W., Kim, J. H., Cho, J., Park, I., Kim, H. Y., Beom, J. H. Tags: INTERVENTIONAL Source Type: research

Perioperative Beta-Blocker for Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis
Conclusions Perioperative use of BB is effective in preventing POAF even in patients undergoing cardiac surgery other than isolated CABG, although it did not translate into improved clinical outcomes. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: The Thoracic and Cardiovascular Surgeon - April 5, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Kim, Sue Hyun Jang, Myoung-jin Hwang, Ho Young Tags: Original Cardiovascular Source Type: research